GO
Loading...

AmerisourceBergen

More

  • *McKesson says fails to get 75 pct threshold. FRANKFURT, Jan 13- U.S. drugs wholesaler group McKesson said on Monday it had failed to win enough support for a $8.4 billion offer to buy German distributor Celesio, leaving it empty-handed in a sector where cross-border consolidation is accelerating.

  • FRANKFURT, Jan 9- U.S. drugs wholesaler McKesson raised its offer for German peer Celesio to about 6.2 billion euros including debt, mollifying an activist hedge fund that had been blocking the deal. McKesson increased its bid to 23.50 euros per Celesio share from the 23 euros it offered in October, the San Francisco- based company said on Thursday.

  • *McKesson makes 23 eur/ shr public tender offer for Celesio. FRANKFURT, Oct 24- McKesson agreed to buy German peer Celesio on Thursday for $8.3 billion, including debt, forging a global market leader in drugs distribution to boost its purchasing power with pharma majors.

  • After-Hours Buzz: ORCL, MCD, CSCO & More Wednesday, 18 Sep 2013 | 6:18 PM ET

    Check out which companies are making headlines after the bell Wednesday:

  • Bulls eyeing new target as the S&P approaches 1700 Tuesday, 23 Jul 2013 | 6:21 PM ET

    Within days of breaking through to record highs, stocks are set to smash through another milestone, but after 1700, the path for the S&P 500 is less certain.

  • A Make-or-Break Week Ahead for the Stock Market Saturday, 20 Apr 2013 | 12:30 AM ET

    It's make-or-break time for the first-quarter earnings season, and it comes just as the stock market is showing signs of strain.

  • Early Movers: FDX, LEN, GIS & More Wednesday, 20 Mar 2013 | 7:57 AM ET

    Some of the names on the move ahead of the open.

  • Traders on the floor of the NYSE

    Stocks cut their losses in the final hour of trading to close narrowly mixed Tuesday, after lawmakers in Cyprus overwhelmingly voted against the controversial bank bailout deal.

  • Midday Movers: C, CHK, EBAY & More Tuesday, 19 Mar 2013 | 12:23 PM ET

    Take a look at some of Tuesday's midday movers:

  • Walgreen to Take 23% Stake in AmerisourceBergen Tuesday, 19 Mar 2013 | 11:30 AM ET

    Walgreen and partner Alliance Boots will take up to a 23 percent stake in AmerisourceBergen, ending Walgreen's current contract with Cardinal Health.

  • Retirement Crisis: Poor Boomers on the Horizon Tuesday, 19 Mar 2013 | 9:54 AM ET

    Americans are living longer and don't have anywhere near enough saved for retirement, a dire new study from the Employee Benefit Research Institute showed Tuesday.

  • Early Movers: EA, SKUL, LULU & More Tuesday, 19 Mar 2013 | 8:04 AM ET

    Some of the names on the move ahead of the open.

  • Will Tech Earnings Charge Up the Stock Market Rally? Friday, 18 Jan 2013 | 8:33 PM ET
    Google Maps app for Apple ios.

    A flood of earnings reports, including major technology and industrial companies, could make or break the stock market’s surprise January rally in the week ahead.

  • Stocks Slide as Fed, ECB Decisions Loom Tuesday, 31 Jul 2012 | 4:02 PM ET

    Stocks closed out another quiet session with modest losses, as investors maintained a wait-and-see approach to the Federal Reserve policy decision tomorrow and the ECB meeting on Thursday.

  • Each quarter near the end of the earnings season, CNBC.com publishes a list of 20 stocks in the S&P 500 index trading at the greatest premiums or discounts to their analysts’ consensus target prices. Here they are.

  • What's Shaking: Monday's Early Movers Monday, 13 Feb 2012 | 8:19 AM ET

    Take a look at some of Monday morning's early movers:

  • 20 Stocks with the Potential to Pop (Q4 2011) Wednesday, 21 Dec 2011 | 4:31 PM ET
    It's the basic question when investing in a stock: is it on the way up or down?To answer this question, the street has developed numerous ways of attempting to predict what will happen, estimating various attributes tied to stock performance in order to determine what the future holds for a company's valuation. After dissecting the data, analysts following a particular stock produce a price target of where they believe the stock is headed. With data from Thomson Reuters, CNBC.com took a look at

    From the entire S&P 500, which stocks are analysts expecting to have the biggest pops? Click to find out.

  • Painful Costs of Counterfeit Prescription Drugs Tuesday, 4 Oct 2011 | 1:17 PM ET
    Counterfeit prescription pharmaceuticals are widely recognized as a growing public health risk and a serious concern to public health officials, private companies, and consumers. This slideshow presents a shortened overview of the longer report,  In some countries around the world, counterfeit prescription drugs comprise as much as 70% of the drug supply and have been responsible for thousands of deaths in some of the world’s most impoverished nations, according to the World Health Organization

    Counterfeit prescription pharmaceuticals are widely recognized as a growing public health risk and a serious concern to public health officials, private companies, and consumers. Learn more.

  • Counterfeit prescription pharmaceuticals are a growing trend, widely recognized as a public health risk and a serious concern to public health officials, private companies, and consumers.  In this CNBC.com special report, we take an in-depth look at the world of counterfeit pharmaceuticals, from the dangers they pose and where they’re made, to what is being done to combat them.

  • Replacing Oprah and the Shift to Cable Thursday, 26 May 2011 | 11:30 AM ET
    Oprah Winfrey

    Oprah's absence will deal a blow across the broadcast networks — to CBS which distributed the syndicated show, as well as airing it on its affiliates, along with ABC, Fox and NBC. And it wasn't just a place filler — Oprah's reliable ratings played a key role drawing viewers into local newscasts.

Most Popular Video

Tuesday, 15 Apr 2014 | 4:07 PM ET

"Yahoo's core business is still limping along," says Colin Gillis, BGC Financial, while providing instant reaction to Yahoo's quarterly numbers. "Shark Tank" investor Kevin O'Leary and "The Profit's" Marcus Lemonis weigh in.

Tuesday, 15 Apr 2014 | 11:31 PM ET

John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, discusses his company's acquisitions in Singapore and India.

Tuesday, 15 Apr 2014 | 11:14 PM ET

Will Oswald, Global Head of FICC Research at Standard Chartered, says Beijing has the tools to guide its economy to a soft landing.